Etsuro Ohta

965 total citations
23 papers, 764 citations indexed

About

Etsuro Ohta is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Etsuro Ohta has authored 23 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 13 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Etsuro Ohta's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (6 papers) and Plant Gene Expression Analysis (5 papers). Etsuro Ohta is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (6 papers) and Plant Gene Expression Analysis (5 papers). Etsuro Ohta collaborates with scholars based in Japan, Czechia and Canada. Etsuro Ohta's co-authors include Fumiya Obata, Fumitaka Kawakami, Tatsunori Maekawa, Makoto Kubo, Kazuko Hasegawa, Shoji Tsuji, Hiroko Maruyama, Manabu Funayama, Naoki Shimada and Takafumi Ichikawa and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Biochemical and Biophysical Research Communications.

In The Last Decade

Etsuro Ohta

22 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Etsuro Ohta Japan	14	591	324	251	199	197	23	764
Philip J. Webber United States	9	696 1.2×	367 1.1×	274 1.1×	267 1.3×	198 1.0×	9	903
Ana Gorostidi Spain	20	607 1.0×	303 0.9×	228 0.9×	224 1.1×	204 1.0×	30	891
Shabnam Salehi‐Rad Canada	11	457 0.8×	249 0.8×	217 0.9×	164 0.8×	211 1.1×	13	660
Marta Blázquez Estrada Spain	14	398 0.7×	283 0.9×	118 0.5×	168 0.8×	197 1.0×	42	654
Shamol Saha United States	10	444 0.8×	404 1.2×	209 0.8×	121 0.6×	229 1.2×	13	849
Iakov N. Rudenko United States	11	438 0.7×	406 1.3×	173 0.7×	102 0.5×	160 0.8×	13	736
Karen Nuytemans United States	13	570 1.0×	347 1.1×	159 0.6×	217 1.1×	277 1.4×	33	877
S. Lincoln United States	14	942 1.6×	341 1.1×	273 1.1×	410 2.1×	465 2.4×	16	1.1k
Jonathan C. Grima United States	10	406 0.7×	517 1.6×	178 0.7×	108 0.5×	186 0.9×	10	903
Ellen Corsmit Belgium	14	312 0.5×	425 1.3×	558 2.2×	149 0.7×	203 1.0×	21	949

Countries citing papers authored by Etsuro Ohta

Since Specialization

Citations

This map shows the geographic impact of Etsuro Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuro Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuro Ohta more than expected).

Fields of papers citing papers by Etsuro Ohta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuro Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuro Ohta. The network helps show where Etsuro Ohta may publish in the future.

Co-authorship network of co-authors of Etsuro Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Etsuro Ohta. A scholar is included among the top collaborators of Etsuro Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuro Ohta. Etsuro Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inahashi, Yuki, Makoto Itakura, Masato Iwatsuki, et al.. (2022). Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells. Pharmaceuticals. 16(1). 5–5. 3 indexed citations

Hattori, A, Etsuro Ohta, Makiko Nagai, Kazuya Iwabuchi, & Hideyuki Okano. (2021). A new approach to analysis of intracellular proteins and subcellular localization using cellprofiler and imageJ in combination. Methods. 203. 233–241. 5 indexed citations

Ohta, Etsuro, Takefumi Sone, Hideki Ukai, et al.. (2020). Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2. Stem Cell Research. 49. 102073–102073. 6 indexed citations

Kubo, Makoto, Ryuichi Nagashima, Fumitaka Kawakami, et al.. (2020). Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells. International Journal of Molecular Sciences. 21(5). 1890–1890. 13 indexed citations

Kubo, Kin‐ya, Ayumi Suzuki, Mitsuo Iinuma, et al.. (2018). Vulnerability to stress in mouse offspring is ameliorated when pregnant dams are provided a chewing stick during prenatal stress. Archives of Oral Biology. 97. 150–155. 5 indexed citations

Murakami, Nagahisa, Taizo Ishikawa, Takayuki Kondo, et al.. (2017). Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation. Stem Cell Research. 24. 36–39. 1 indexed citations

Kubo, Makoto, Ryuichi Nagashima, Etsuro Ohta, et al.. (2016). Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses. Journal of Neuroimmunology. 292. 1–8. 16 indexed citations

Ohta, Etsuro, Tomoko Nihira, A Uchino, et al.. (2015). I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway. Human Molecular Genetics. 24(17). 4879–4900. 56 indexed citations

Kawakami, Fumitaka, Naoki Shimada, Etsuro Ohta, et al.. (2013). Leucine‐rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase‐3β. FEBS Journal. 281(1). 3–13. 51 indexed citations

10.

Ohta, Etsuro, Fumitaka Kawakami, Makoto Kubo, & Fumiya Obata. (2012). Dominant-negative effects of LRRK2 heterodimers: A possible mechanism of neurodegeneration in Parkinson’s disease caused by LRRK2 I2020T mutation. Biochemical and Biophysical Research Communications. 430(2). 560–566. 12 indexed citations

11.

Kawakami, Fumitaka, Etsuro Ohta, Tatsunori Maekawa, et al.. (2012). LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth. PLoS ONE. 7(1). e30834–e30834. 98 indexed citations

12.

Maekawa, Tatsunori, Yui Sasaki, Takashi Miyajima, et al.. (2012). The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities. Molecular Neurodegeneration. 7(1). 15–15. 37 indexed citations

13.

Ohta, Etsuro, Fumitaka Kawakami, Makoto Kubo, & Fumiya Obata. (2011). LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations. FEBS Letters. 585(14). 2165–2170. 56 indexed citations

14.

Kawakami, Fumitaka, Naoki Shimada, Go Kagiya, et al.. (2011). Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3β. FEBS Journal. 278(24). 4895–4904. 68 indexed citations

15.

Kubo, Makoto, Ryuichi Nagashima, Tatsunori Maekawa, et al.. (2010). LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation. Journal of Neuroimmunology. 229(1-2). 123–128. 31 indexed citations

16.

Maekawa, Tatsunori, et al.. (2010). Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen. Biochemical and Biophysical Research Communications. 392(3). 431–435. 35 indexed citations

17.

Ohta, Etsuro, Fumitaka Kawakami, Tatsunori Maekawa, et al.. (2009). I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule. Biochemical and Biophysical Research Communications. 390(3). 710–715. 23 indexed citations

18.

Ohta, Etsuro, Makoto Kubo, & Fumiya Obata. (2009). Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis. Biochemical and Biophysical Research Communications. 391(1). 242–247. 20 indexed citations

19.

Ohta, Etsuro, Manabu Funayama, Hiroshi Ichinose, et al.. (2006). Novel Mutations in the Guanosine Triphosphate Cyclohydrolase 1 Gene Associated With DYT5 Dystonia. Archives of Neurology. 63(11). 1605–1605. 4 indexed citations

20.

Funayama, Manabu, Kazuko Hasegawa, Etsuro Ohta, et al.. (2005). An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Annals of Neurology. 57(6). 918–921. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact